Stay updated on mFOLFIRINOX +/- Ramucirumab Clinical Trial
Sign up to get notified when there's something new on the mFOLFIRINOX +/- Ramucirumab Clinical Trial page.

Latest updates to the mFOLFIRINOX +/- Ramucirumab Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe Publications section now notes that entries are automatically filled from PubMed, and the revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check25 days agoChange DetectedThe site-wide banner about government funding and operating status has been removed. Study details and eligibility criteria remain unchanged.SummaryDifference0.3%

- Check46 days agoChange DetectedNo significant additions or removals are detected. The page remains focused on the study overview, eligibility criteria, and locations.SummaryDifference0.4%

- Check68 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference3%

- Check75 days agoChange DetectedThe page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.SummaryDifference0.4%

- Check89 days agoChange DetectedThe page version is updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed. No changes to core content, pricing, stock, or time-slot information were detected.SummaryDifference0.2%

Stay in the know with updates to mFOLFIRINOX +/- Ramucirumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the mFOLFIRINOX +/- Ramucirumab Clinical Trial page.